# Takeda Oncology

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/takeda-oncology/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company in Cambridge, United States |
| OpenAlex ID | https://openalex.org/F4320333265 |
| Works | 1,947 |

## Funder papers

- [Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer](https://scholariq.org/papers/niraparib-in-patients-with-newly-diagnosed-advanced-ovarian-cancer/)
- [Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers](https://scholariq.org/papers/molecular-biomarkers-of-disease-outcomes-and-mechanisms-of-acquired-resistance/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.